Biotech Analysts, along with Dr. Brian Lester, a leading dermatologist, participates in an Analyst/Industry conference call entitled, “Recent Competitive Landscape Developments in Atopic Dermatitis: A Closer Look at Potential Disruptive Therapies from APGE, CRVS, and KYMR” on January 26 at 9 am.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APGE:
- Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
- Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
- Apogee Therapeutics price target raised to $116 from $109 at Craig-Hallum
- Aligos Therapeutics initiated with a Buy at UBS
- Apogee Therapeutics initiated with a Peer Perform at Wolfe Research